Event News & Resources
Clemmie Ley’s farewell message
Clemmie has been with us for a month during the summer holidays, whilst waiting for results from her GCSE's, and is about to start sixth form to study A-levels in Maths, Further Maths, Chemistry and Physics! "As my time at Neuro-Bio comes to an end, I’ve been...
Neuro-Bio 2022 publications
Since April 2022 Neuro-Bio has had 4 peer-reviewed articles accepted. We are very proud that Neuro-Bio 2022 publications are all in the TOP 5% of journals as they have Impact Factor equal to or greater than 6. Click here to have more information
Neuro-Bio training day
On Thursday the 8th of December, the whole Neuro-Bio team took part in a team building experience, provided by Heather Bunney from Cegos Swiss. During the training, many interactive activities were completed by team. This helped understanding different personalities...
Neuro-Bio’s CEO opens Aptamer Group’s new state-of-the-art laboratories.
On Friday 28th of November Neuro-Bio's CEO, Susan Greenfield, opens Aptamer Group's new state-of-the-art laboratories and presented on the challenges in scientific discovery. To read the full article, click the link.
Allies of Neuro-Bio
Neuro-Bio has launched a new webpage called "Allies of Neuro-Bio" in which people living with Alzheimer’s Disease and their careers can send their thoughts. Neuro-Bio will only be able to post a limited number and the page will simply be a notice board, not a...
Neuro-Bio’s manuscript accepted for publication
Neuro-Bio's manuscript entitled “ Characterisation of a Bioactive Peptide T14 in the Human and Rodent Substantia nigra: Implications for Neurodegenerative Disease” has been accepted for publication at the International Journal of Molecular Sciences. To read the full...
Alzheimer’s association webinar on the 1st of December
On Thursday the 1st of December Neuro-Bio's CEO, Susan Greenfield will host a webinar for the Alzheimer's association. See information below on how to register and participate at the webinar.